Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0001209191-22-057421

Options or other derivatives

  • Director acquired 35,235 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
DiRocco Derek Director 2022-11-14 Grant or award · Stock Option (Right to Buy) +35,235 35,235 D: show line 1 in the form
Loading xslF345X03/doc4.xml…